Global Medical Grade Carboxymethyl Cellulose Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Medical Grade Carboxymethyl Cellulose Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Carboxymethyl cellulose (also referred as CMC and Sodium Carboxymethyl Cellulose) can be described as an anionic water-soluble polymer produced from naturally occurring cellulose by etherification, substituting the hydroxyl groups with carboxymethyl groups on the cellulose chain.
Medical Grade Carboxymethyl Cellulose report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Medical Grade Carboxymethyl Cellulose market is projected to reach US$ 203.6 million in 2029, increasing from US$ 151 million in 2022, with the CAGR of 4.2% during the period of 2024 to 2029. Demand from Liquid Preparation and Solid Preparations are the major drivers for the industry.
The medical-grade carboxymethyl cellulose (CMC) market is driven by the increasing demand for CMC in various medical applications, such as wound care, ophthalmic solutions, and pharmaceutical formulations. Medical-grade CMC offers advantages like biocompatibility, excellent moisture retention, and ease of gel formation, making it suitable for wound healing and other medical uses. The rise in chronic diseases, aging population, and the need for advanced wound care solutions fuel market growth. Moreover, the growing use of CMC in the pharmaceutical industry to improve drug stability and release further contributes to market expansion. However, the market also faces challenges, including the availability of alternative materials and the need for stringent regulatory compliance to ensure the safety and efficacy of medical-grade CMC products. To succeed, manufacturers must focus on innovation, adhere to quality standards, and collaborate with healthcare providers to explore new medical applications and address the challenges to meet the increasing demand for medical-grade carboxymethyl cellulose.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Medical Grade Carboxymethyl Cellulose market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
CP Kelco
Lihong Fine Chemicals
Akzo Nobel
Wealthy
Shanghai Shengguang Edible Chemicals
Yingte Chemical
Weifang Lude Chemical
Amtex Corp
Ugur Seluloz Kimya AS
Weiyi Chem
Shanhe
Segment by Type
Purity (99.5 %+)
Purity (90%-99.5%)
Purity (50%-90%)
Liquid Preparation
Solid Preparations
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Medical Grade Carboxymethyl Cellulose market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Medical Grade Carboxymethyl Cellulose, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Medical Grade Carboxymethyl Cellulose industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Medical Grade Carboxymethyl Cellulose in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Medical Grade Carboxymethyl Cellulose introduction, etc. Medical Grade Carboxymethyl Cellulose Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Medical Grade Carboxymethyl Cellulose market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Medical Grade Carboxymethyl Cellulose report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Medical Grade Carboxymethyl Cellulose market is projected to reach US$ 203.6 million in 2029, increasing from US$ 151 million in 2022, with the CAGR of 4.2% during the period of 2024 to 2029. Demand from Liquid Preparation and Solid Preparations are the major drivers for the industry.
The medical-grade carboxymethyl cellulose (CMC) market is driven by the increasing demand for CMC in various medical applications, such as wound care, ophthalmic solutions, and pharmaceutical formulations. Medical-grade CMC offers advantages like biocompatibility, excellent moisture retention, and ease of gel formation, making it suitable for wound healing and other medical uses. The rise in chronic diseases, aging population, and the need for advanced wound care solutions fuel market growth. Moreover, the growing use of CMC in the pharmaceutical industry to improve drug stability and release further contributes to market expansion. However, the market also faces challenges, including the availability of alternative materials and the need for stringent regulatory compliance to ensure the safety and efficacy of medical-grade CMC products. To succeed, manufacturers must focus on innovation, adhere to quality standards, and collaborate with healthcare providers to explore new medical applications and address the challenges to meet the increasing demand for medical-grade carboxymethyl cellulose.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Medical Grade Carboxymethyl Cellulose market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
CP Kelco
Lihong Fine Chemicals
Akzo Nobel
Wealthy
Shanghai Shengguang Edible Chemicals
Yingte Chemical
Weifang Lude Chemical
Amtex Corp
Ugur Seluloz Kimya AS
Weiyi Chem
Shanhe
Segment by Type
Purity (99.5 %+)
Purity (90%-99.5%)
Purity (50%-90%)
Segment by Application
Liquid Preparation
Solid Preparations
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Medical Grade Carboxymethyl Cellulose market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Medical Grade Carboxymethyl Cellulose, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Medical Grade Carboxymethyl Cellulose industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Medical Grade Carboxymethyl Cellulose in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Medical Grade Carboxymethyl Cellulose introduction, etc. Medical Grade Carboxymethyl Cellulose Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Medical Grade Carboxymethyl Cellulose market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices